Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

Post-Approval Research: Do You Have What It Takes?

THE XTALKS BLOG

Clinical Research

At the core of revolutionizing post-approval research is understanding the fundamental differences in conducting research in pre-market randomized controlled trials (RCT) versus post-approval research.

Tweetables from this article:

Tweet: Post-approval #clinicalresearch has a unique set of challenges, such as massive scope, and lengthy time horizons. http://ctt.ec/MBI3S+Post-approval research has a unique set of challenges, such as massive scope, and lengthy time horizons.

Share this!

September 21, 2016 | by Lori Jones, Marketing Manager, Bioclinica

Investments in post-approval research are rising steadily year on year. Chances are, post-approval research represents a substantial part of a pharmaceutical, biotech, or medical device organization’s annual budget. But how much of that money is being wasted by conducting post-approval studies in an inappropriate and inefficient manner? Bioclinica’s free webinar Conducting Post-Approval Research Requires A Unique Mindset And Specialized Infrastructure. Do You Have What It Takes? shows how to reduce your post-approval research spend while simultaneously optimizing your study outcomes.

At the core of revolutionizing post-approval research is understanding the fundamental differences in conducting research in pre-market randomized controlled trials (RCT) versus post-approval research. For example:

  • Post-approval research is performed to satisfy a wide variety of business needs – it is not simply about whether drugs are safe and effective (the primary goals of Phase I, II, and III clinical trials).
  • Post-approval research has a unique set of challenges, such as massive scope, research-naïve physicians, and lengthy time horizons.
  • Post-approval research is not subject to the same regulatory requirements demanded in pre-market RCTs.


If the differences between pre-market RCTs and post-approval studies are not appreciated, then post-approval research becomes burdened by unnecessary rigor, inappropriate design, and inefficient execution. This results in inflated costs and increased resource burn. Studies can quickly become cost-prohibitive.

In contrast, treating post-approval research for what it is – not as a modified Phase I, II, or III trial – streamlines the operational processes involved, reduces costs, and enhances outcomes. For example, a successful post-approval study will utilize:

  • A patient-centric methodology for the design and implementation of the study
  • SOPs that are specifically-designed to meet the objectives of the study
  • Smart technology to improve the flow of communication and contain study costs
  • Centralized remote monitoring to support sites and ensure regulatory standards are met
  • A flexible, scalable, customizable technological infrastructure geared for post-approval research

With the pressing need to obtain real-world data, assess product safety profiles, and support the full span of a product’s lifecycle, the ability to conduct efficient, cost-effective post-approval studies is more important than ever.

View the webinar now to discover what it takes to conduct successful post-approval studies in today’s complex pharmaceutical environment.

For more information on Bioclinica’s post-approval research services, click here.

This blog post was originally published at: Post-Approval Research: Do You Have What It Takes?

How do you manage the challenges of post-approval research? Share your thoughts in the comments section below!



Keywords: Post-Approval Research, Randomized Controlled Trials, Real-World Data


| NEXT ARTICLE | MORE BLOG POSTS | NEWS | VIDEOS | POLLS & QUIZZES | WEBINARS |

 

        Share this with your colleagues!




        READ THESE NEXT
        Adding Value to your Food Products by Adding Live Cultures: Interview with a Probiotic Expert

        February 17, 2017 - To better understand how probiotics can be added to food products, and the benefits of probiotic fortification for both food manufacturers and consumers, I spoke with Michael Bush, president of the probiotic research and product development company, Ganeden. With over 20 years of experience in business and a degree in biomedical technology, Bush knows how formulating with functional ingredients like probiotics can help food and beverage companies add value to their products and increase sales.


        Dirty Little Secret: How Clean Are Restaurant Tablets?

        February 8, 2017 - The digital revolution may well make it easier or more fun to process your order, but these devices shouldn’t be an overlooked source of potential cross-contamination.


        5 Ways Mature Material Handling Workflows Can Benefit Your Manufacturing Business

        February 2, 2017 - Sometimes inefficiencies in material handling workflows are obvious, however without the right tools to improve these processes, manufacturers could get stuck with a sub-par process. So what defines a mature material handling workflow?

        LEAVE A COMMENT
         
          
        THE XTALKS VITALS WEBINAR PRODUCTION TIPS BLOG

        Top Ten Webinar Production Tips of 2016

        REGISTER FOR THESE WEBINARS

        ICH-GCP E6(R2) – Live Q&A with GCP Inspector and Investigator Site Perspectives


        Addressing HACCP of Frictionless Devices in the Food Service Industry


        Mid-Study Changes: Keeping Your Clinical Trial on Track with EDC


        The Growing Formulation Trend: Probiotics


        Copyright © 2016-2017 Honeycomb Worldwide Inc.